Protocol outlines co-culture of cardiomyocytes and endothelial cells, highlighting its potential for vascularized heart models.
Here, we present a protocol for building a vascularized heart-on-a-chip by co-encapsulating human induced pluripotent stem cell (hiPSC)-derived cardiomyocytes and endothelial cells in vascular endothelial growth factor (VEGF)- and aprotinin-supplemented fibrin. We describe steps for cell preparation, fibrin formulation, chip loading, optional droplet-based pilot or high-throughput setups, and imaging. We then detail procedures for immunofluorescence staining and routine quantitative analysis of vascular and contractile features during culture for up to three weeks.
No takes yet. Share an insight, caveat, or question.
Spanjersberg et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: